Clinical trials for Dry eye syndrome

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Dry eye syndrome. For all clinical trials, go to clinical trials search

This list shows clinical trials for Dry eye syndrome

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Dry eye syndrome
Title Recruitment status Location
Eyelid massager effectiveness in meibomian gland dysfunction Recruiting United Kingdom
TearLab Core Validation Study Recruiting United Kingdom
Lamelleye vs Comparator for the Treatment of Dry Eye Disease Recruiting United Kingdom
Optive Brand For Day And Night Dry Eye Management Recruiting United Kingdom
6-MONTHS EFFICACY AND SAFETY CLINICAL TRIAL FOLLOWED BY 6-MONTHS OF SAFETY EVALUATION OF CYCLOKAT® 1MG/ML (CICLOSPORIN) EYE DROPS, EMULSION ADMINISTERED ONCE DAILY IN ADULT PATIENTS WITH SEVERE DRY EYE DISEASE (DED) Not Recruiting United Kingdom
Comparison of an Investigational Eye Drop Formulation with OPTIVE™ Unit-Dose for 3 Months in Subjects with Dry Eye Disease Not Recruiting United Kingdom
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease. Not Recruiting United Kingdom
An evaluation of the Ocular Surface Health in Subjects Using DuoTrav APS Eye Drops Solution Versus XALACOM® EYE Drops Solution - DuoTrav APS versus XALACOM® in OSDI Not Recruiting United Kingdom
6-MONTHS EFFICACY AND SAFETY CLINICAL TRIAL FOLLOWED BY 6-MONTHS OF SAFETY EVALUATION OF CYCLOKAT® 1MG/ML (CICLOSPORIN) EYE DROPS, EMULSION ADMINISTERED ONCE DAILY IN ADULT PATIENTS WITH SEVERE DRY EYE DISEASE (DED) Not Recruiting United Kingdom
6-MONTHS EFFICACY AND SAFETY CLINICAL TRIAL FOLLOWED BY 6-MONTHS OF SAFETY EVALUATION OF CYCLOKAT® 1MG/ML (CICLOSPORIN) EYE DROPS, EMULSION ADMINISTERED ONCE DAILY IN ADULT PATIENTS WITH SEVERE DRY EYE DISEASE (DED) Not Recruiting United Kingdom

Page last reviewed: 17/03/2016

Next review due: 01/03/2019